NCT02497651

Brief Summary

The study aims to evaluate the effect of smoking on postprandial responses such as plasma glucose, secretion of gut - and pancreatic hormones and gastric emptying in healthy, heavy smoking men.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable diabetes-mellitus

Timeline
Completed

Started May 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 25, 2015

Completed
19 days until next milestone

First Posted

Study publicly available on registry

July 14, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

August 7, 2017

Status Verified

August 1, 2017

Enrollment Period

5 months

First QC Date

June 25, 2015

Last Update Submit

August 4, 2017

Conditions

Keywords

SmokingDiabetesIncretin hormonesGlucose tolerance

Outcome Measures

Primary Outcomes (1)

  • Postprandial response of glucagon-like peptide-1 (GLP-1)

    Incremental and total area under the Concentration-Time Curve (AUC 0-240 min)

    -30, -20, -10, 0, 10, 20, 30, 50, 70, 90, 120, 150, 180, 240 minutes (meal tests start at 0 min)

Secondary Outcomes (10)

  • Postprandial response of insulin

    -30, -20, -10, 0, 10, 20, 30, 50, 70, 90, 120, 150, 180, 240 minutes (meal tests start at 0 min)

  • Postprandial response of Glukagon

    -30, -20, -10, 0, 10, 20, 30, 50, 70, 90, 120, 150, 180, 240 minutes (meal tests start at 0 min)

  • Postprandial response of CCK

    -30, -20, -10, 0, 10, 20, 30, 50, 70, 90, 120, 150, 180, 240 minutes (meal tests start at 0 min)

  • Postprandial response of Gastrin

    -30, -20, -10, 0, 10, 20, 30, 50, 70, 90, 120, 150, 180, 240 minutes (meal tests start at 0 min)

  • Postprandial response of GIP

    -30, -20, -10, 0, 10, 20, 30, 50, 70, 90, 120, 150, 180, 240 minutes (meal tests start at 0 min)

  • +5 more secondary outcomes

Study Arms (2)

Healthy, heavy smoking men

EXPERIMENTAL

Twelve healthy, male subjects. Intervention: Will undergo two separate, identical test days. One absent smoking, and one with concomitant smoking.

Dietary Supplement: Liquid mixed mealOther: Skin Biopsy

Healthy, non-smoking men

EXPERIMENTAL

Twelve healthy, male subjects. Intervention: Will undergo a liquid mixed meal test and a skin biopsy.

Dietary Supplement: Liquid mixed mealOther: Skin Biopsy

Interventions

Liquid mixed mealDIETARY_SUPPLEMENT

The subjects will ingest a 400 ml chocolate drink, rich on carbohydrates, fat and lipids. In the following 4 hours, blood samples will be drawn from a PVC for the measurement of plasma glucose, gut- and pancreatic hormones, acetaminophen etc. After the 4 hours, the subjects will be offered an ad libitum meal.

Healthy, heavy smoking menHealthy, non-smoking men

All subjects will undergo a skin biopsy procedure. Two small (3 mm) biopsies will be taken from the hip area under local anaesthesia. Standard wound treatment will follow.

Healthy, heavy smoking menHealthy, non-smoking men

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Both groups
  • Caucasian ethnicity
  • Healthy males
  • Normal haemoglobin
  • Age above 18 years
  • Informed and written consent
  • BMI \>20 kg/m2
  • Smokers • Minimum 20 cigarettes pr. day for at least 1 year
  • Non-smokers
  • No smoking on a regular basis

You may not qualify if:

  • Both groups
  • Diabetes or prediabetes (fasting plasma glucose levels \>6.5 mM or HbA1c \>6.0%)
  • First- or second-degree relatives with diabetes
  • Liver disease (alanine aminotransferase (ALAT) and/or serum aspartate aminotransferase (ASAT) \>2 times normal values) or history of hepatobiliary disorder
  • Gastrointestinal disease, previous intestinal resection, cholecystectomy or any major intra-abdominal surgery
  • Hypo- or hyperphosphataemia
  • Nephropathy (serum creatinine \>150 µM and/or albuminuria
  • Treatment with medicine that cannot be paused for 12 hours
  • Hypo- or hypercalcaemia
  • Hypo- and hyperthyroidism
  • Treatment with oral anticoagulants
  • Active or recent malignant disease
  • Any treatment or condition requiring acute or sub-acute medical or surgical intervention
  • Any condition considered incompatible with participation by the investigators

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Diabetes Research, Department of Medicine, Gentofte Hospital

Hellerup, Copenhagen, 2900, Denmark

Location

Related Publications (1)

  • Grondahl MF, Bagger JI, Lund A, Faurschou A, Rehfeld JF, Holst JJ, Vilsboll T, Knop FK. Effects of Smoking Versus Nonsmoking on Postprandial Glucose Metabolism in Heavy Smokers Compared With Nonsmokers. Diabetes Care. 2018 Jun;41(6):1260-1267. doi: 10.2337/dc17-1818. Epub 2018 Mar 30.

MeSH Terms

Conditions

Diabetes MellitusSmoking

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

June 25, 2015

First Posted

July 14, 2015

Study Start

May 1, 2015

Primary Completion

October 1, 2015

Study Completion

June 1, 2016

Last Updated

August 7, 2017

Record last verified: 2017-08

Locations